| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 08/26/2004 | WO2004050610A3 Modulators of melanocortin receptor |
| 08/26/2004 | US20040167167 Biphenyl derivatives |
| 08/25/2004 | EP1448530A1 Heteroaryl carboxylic acid amides |
| 08/25/2004 | CN1523024A Macromolecule immobilized cinchonine alkaloid ligand, synthesis method and use thereof |
| 08/24/2004 | US6780861 Azabicyclic carbamates and their use as α-7 nicotinic acetylcholine receptor agonists |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1284975B1 Ammonium compounds bearing an electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them |
| 08/12/2004 | US20040157878 Alzheimer 's disease; parkinson's disease; schizophrenia; antidepressants; anxiolytic agents; brain disorders; psychological disorders |
| 08/12/2004 | US20040157844 6-azauracil derivatives as thyroid receptor ligands |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/10/2004 | US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
| 08/05/2004 | WO2004043389A3 Methods of treating cancer and related methods |
| 08/04/2004 | EP1442041A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004035574A8 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 07/29/2004 | WO2004018419B1 Benzimidazole quinolinones and uses thereof |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147583 Anxiolytic agents; Alzheimer's disease |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147522 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis; Down's syndrome; attention deficit disorders; hyperactivity |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/28/2004 | CN1159286C Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004039815A3 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/21/2004 | EP1438309A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 07/21/2004 | EP1438308A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists |
| 07/15/2004 | WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 07/15/2004 | US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 07/15/2004 | US20040138253 Quaternary ammonium compounds |
| 07/15/2004 | US20040138252 Pharmaceutical composition for therapy of interstitial cystitis |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
| 07/14/2004 | EP1436266A2 Methods and compositions of novel triazine compounds |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/08/2004 | US20040133001 Peptide deformylase inhibitors |
| 07/08/2004 | US20040132790 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 07/08/2004 | US20040132768 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/01/2004 | US20040127467 Synthesis of pancratistatin prodrugs |
| 07/01/2004 | DE10257537A1 New N-azabicyclooctyl bicyclic heteroaryl carboxamides, are alpha 7-nicotinic acetylcholine receptor ligands useful for improving attention, concentration, learning and/or memory performance |
| 06/30/2004 | EP1432707A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/29/2004 | US6756400 Diaromatic compound containing 2-amine groups, useful for treating neuropathic pain |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2133089C Novel cyclic amino acids and derivatives thereof |
| 06/24/2004 | WO2004052889A1 Compounds as radioligands for the diagnosis of disease |
| 06/24/2004 | WO2003053966A8 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/24/2004 | US20040122237 Substituted benzazoles and methods of their use as inhibitors of Raf kinase |
| 06/24/2004 | US20040122005 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme |
| 06/24/2004 | DE10257078A1 New N-azabicyclooctyl bicyclic heteroaryl carboxamides, are alpha 7-nicotinic acetylcholine receptor ligands useful for improving attention, concentration, learning and/or memory performance |
| 06/23/2004 | EP1429771A2 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116704 Precipitating, neutralization in presence of Lewic aicd |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/15/2004 | US6750226 For manufacture of medicament for use in therapy of respiratory, urinary or gastrointestinal disease |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110789 Substituted aminoquinuclidine compounds |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/03/2004 | WO2004035574A3 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
| 06/03/2004 | US20040106676 Water-soluble etoposide analogs and methods of use thereof |
| 06/02/2004 | EP1423351A2 Biphenylene compounds |
| 06/02/2004 | EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/01/2004 | US6743914 Using tertiary amine catalyst |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043349A2 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/26/2004 | CN1500088A Isoquinuclidine derivative, process for producing same, and medicinal compsn. contg. same |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/19/2004 | EP1419125A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/13/2004 | WO2004039815A2 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 05/13/2004 | WO2004039801A1 Quinuclidinium derivatives as antimuscarinic agents |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2503786A1 Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases |
| 05/13/2004 | CA2503654A1 Quinuclidinium derivatives as antimuscarinic agents |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417153A1 N,n-dinitramide salts as solubilizing agents for biologically active agents |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 05/06/2004 | US20040087616 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 04/29/2004 | WO2004035575A1 Process for the preparation of (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
| 04/29/2004 | WO2004035574A2 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 04/29/2004 | WO2004034985A2 Chemical compounds |